Clearbridge Investments, LLC

Position in AZN — Astrazeneca PLC

CIK 1348883 NEW YORK, NY

Position in AZN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,017,788,717

New position

Shares Held

5,160,677

first reported quarter

Ownership

0.333%

of shares outstanding

% of Portfolio

0.90%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 96.72732797021165.ToString("F0")% Shared 0.ToString("F0")% None 3.2726720297883456.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clearbridge Investments, LLC holds $3,213,564,917 across 13 Drug Manufacturers - General names. AZN ranks #2 (31.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	5,647,437	$1,380,459,499
2	AZN	Astrazeneca PLC This page	5,160,677	$1,017,788,717
3	LLY	ELI LILLY & Co	466,679	$429,237,343
4	GILD	Gilead Sciences, Inc.	1,231,150	$171,585,375
5	ABBV	AbbVie Inc.	509,075	$110,718,721
6	MRK	Merck & Co., Inc.	577,786	$69,501,877
7	AMGN	Amgen Inc	70,276	$24,726,610
8	BMY	Bristol Myers Squibb Co	101,470	$6,154,155

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,017,788,717	5,160,677	—	Shares	Defined	2026-05-13
No filing history on record for this holder in this stock.